Farmaforum Partnering Day 2025

18 Sept 2025 | Madrid, Spain

Register
Register
Register

ExpertiseUpdated on 25 June 2025

ATMP Developers from Bench to Bedside

Andrea Comella Bolla

Marketing and Strategy Department Lead at Creatio- Universitat de Barcelona

Barcelona, Spain

About

Creatio offers tailored, high-quality support to public and private stakeholders to accelerate the development of ATMPs — from lab to patient.

Our solutions cover the full value chain, from early-stage research to clinical-grade manufacturing, in full compliance with GMP, GLP, and ISO 9001:2015 standards.

Core Activities:

  • GMP-compliant production and validation of gene, cell, and tissue-engineered (3D bioprinted) ATMPs

  • Regulatory and clinical translation support

  • Preclinical studies (efficacy, PK/PD, tolerance, clinical pathology)

  • GLP-compliant toxicology studies (in vitro and in vivo toxicity)

  • Regulatory and preclinical support

  • Scientific and technical training

Whether you're an academic lab, biotech startup, SME, or pharmaceutical company, Creatio is your strategic partner to develop and deliver next-generation therapies with real clinical and societal impact.

Similar opportunities